Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Product Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00725608
What this trial is testing

Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)

Who this might be right for
Opioid-Related DisordersOpiate DependenceDrug Abuse
Indivior Inc. 339
Testing effectiveness (Phase 2)Study completedNCT04755647
What this trial is testing

Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Sanotize Research and Development corp. 40
Not applicableActive Not RecruitingNCT03967158
What this trial is testing

Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice

Who this might be right for
Coronary Artery DiseaseCoronary Disease
Seung-Jung Park 2,000
Not applicableStudy completedNCT01408615
What this trial is testing

A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)

Who this might be right for
Infertility, Female
Organon and Co 472
Not applicableLooking for participantsNCT06857058
What this trial is testing

Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis

Who this might be right for
Intracranial Atherosclerotic Stenosis
Sino Medical Sciences Technology Inc. 300
Early research (Phase 1)UnknownNCT05509985
What this trial is testing

ASKG315 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AskGene Pharma, Inc. 100
Large-scale testing (Phase 3)Study completedNCT00445874
What this trial is testing

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Vistakon Pharmaceuticals 120
Not applicableUnknownNCT01992484
What this trial is testing

Platelet Function in Patients With an Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome (ACS)
Medical University of Vienna 1,000
Not applicableUnknownNCT04568668
What this trial is testing

Evaluating ActionADE in Reducing Adverse Drug Reactions

Who this might be right for
Adverse Drug EventAdverse Drug Reaction
University of British Columbia 3,600
Testing effectiveness (Phase 2)Study completedNCT03557281
What this trial is testing

An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 76
Large-scale testing (Phase 3)Study completedNCT00129363
What this trial is testing

Study to Evaluate the Safety of Twice Daily Oral Carvedilol

Who this might be right for
Congestive Heart Failure
Shaddy, Robert, M.D. 75
Post-approval studies (Phase 4)UnknownNCT01605721
What this trial is testing

Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

Who this might be right for
Coronary Artery Disease
Seoul National University Hospital 2,000
Large-scale testing (Phase 3)Ended earlyNCT01453049
What this trial is testing

An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 86
Early research (Phase 1)Study completedNCT00717925
What this trial is testing

Study Evaluating Safety and Tolerability of Inotuzumab Ozogamicin (CMC-544) in Japanese Patients With B-cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Lymphoma, B-Cell
Wyeth is now a wholly owned subsidiary of Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT00016718
What this trial is testing

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 43
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Early research (Phase 1)Study completedNCT01739647
What this trial is testing

A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects

Who this might be right for
Healthy Young VolunteersHealthy Elderly Volunteers
AstraZeneca 72
Large-scale testing (Phase 3)Study completedNCT06840158
What this trial is testing

Double-blind Comparative Randomized Multicenter

Who this might be right for
Cerebral Palsy (CP)
Innopharm LLC 80
Large-scale testing (Phase 3)Looking for participantsNCT06561048
What this trial is testing

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaFollicular T-Cell Lymphoma+4 more
Corvus Pharmaceuticals, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01047540
What this trial is testing

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

Who this might be right for
HSV-2
AiCuris Anti-infective Cures AG 156
Next Page